Tag: managers

Upcoming online event to feature 15-plus speakers and world-class educational and networking opportunities, with a focus on unlocking true value in equity markets

Upcoming online event to feature 15-plus speakers and world-class educational and networking opportunities, with a focus on unlocking true value in equity markets

LEXINGTON, Ky., July 23, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB, METCL, METCZ) ("Ramaco Resources" or the "Company"), an operator and developer of...

Exploring Digital Asset Strategies to Inform Future Capital Innovation

Exploring Digital Asset Strategies to Inform Future Capital Innovation

The Flex complements the original WaveCore, which penetrates thick concrete floors and walls in the interior, to lower the cost of roof-to-indoor, building-to-building and...

ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), announced today the pricing of an underwritten offering of (i) 8,250,000 of its ordinary shares at a price of $20.00 per share and (ii) to one investor, pre-funded warrants to purchase 500,000 ordinary shares at a price of $19.99 per pre-funded warrant, which represents the per share public offering price for the ordinary shares less the $0.01 per share exercise price for each such pre-funded warrant. All shares and pre-funded warrants in the offering are to be sold by Pharvaris. In addition, Pharvaris has granted the underwriters a 30-day option to purchase up to an additional 1,312,500 ordinary shares at the public offering price, less underwriting discounts and commissions. The gross proceeds to Pharvaris from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $175 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about July 24, 2025, subject to satisfaction of customary closing conditions.

Trusted global manufacturing and supply chain leader delivers best-in-class injectionmolding experience with advanced DFM tools and unmatched mold build visibility SAN FRANCISCO, July 22, 2025...

TUCSON, Ariz., July 22, 2025 /PRNewswire/ -- Group2FA®, the pioneering provider of multiuser two-factor authentication (2FA) for shared accounts, today announced several new features...

TORONTO, July 21, 2025 /CNW/ - Bank of Montreal (TSX: BMO) (NYSE: BMO or the "Bank") today announced the pricing of USD 1.0 billion...

NetworkNewsWire Editorial Coverage NEW YORK, July 21, 2025 /PRNewswire/ -- Gold's remarkable surge beyond $3,300 per ounce (all figures are in U.S. dollars unless otherwise noted)...

NetworkNewsWire Editorial Coverage NEW YORK, July 21, 2025 /PRNewswire/ -- Gold's remarkable surge beyond $3,300 per ounce (all figures are in U.S. dollars unless otherwise noted)...

NetworkNewsWire Editorial Coverage NEW YORK, July 21, 2025 /CNW/ -- Gold's remarkable surge beyond $3,300 per ounce (all figures are in U.S. dollars unless otherwise noted)...

SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Uni-Fuels Holdings Limited (NASDAQ: UFG), (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced that its wholly-owned subsidiary, Uni-Fuels Pte Ltd (“Uni-Fuels Singapore”), has successfully completed the Company’s first-ever commercial paper (“CP”) issuance, raising USD 3 million through ADDX, a private market platform regulated by the Monetary Authority of Singapore. The offering was oversubscribed, reflecting strong demand from accredited investors.

Rebrand highlights firm's evolution, transformational combination with Portfolio Advisors and commitment to delivering differentiated performanceNew Private Market Outlook urges investors to embrace a more...